This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Tuesday, July 8, 2014
Amazing - Peek Inside the 21st Century Doctor's Bag
A Peek Inside the 21st Century Doctor's Bag: Mobile Health Technologies for Medical Education from Academic Medicine on Vimeo.
A Peek Inside the 21st Century Doctor's Bag: Mobile Health Technologies for Medical Education from Academic Medicine
Shiv Gaglani is a medical student at Johns Hopkins and an editor of Medgadget, which covers innovations in medical technology. He curated the Smartphone Physical, which debuted at TEDMED in 2013, and is interested in the potential of mobile health technologies to improve medical education and clinical exam skills. In this video, Shiv, co-author of a recent Academic Medicine commentary with Dr. Eric Topol, demos three mobile health technologies: the smartphone-based electrocardiogram, ophthalmoscope, and stethoscope.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment